POLARISqb and PhoreMost Partner to Use QC for Drug Discovery

POLARISqb, a quantum software company based in Durham, North Carolina, will work with PhoreMost, a drug discovery company in the UK, to help find potential drug targets that have previously been considered undruggable. PhoreMost's SITESEEKER phenotypic screen platform identifies unexpected or “cryptic” druggable sites across the entire genome, within targets previously considered undruggable and then POLARISqb Tachyon™ quantum computing platform will use quantum algorithms to scan for billions of molecules from a large chemical space to find novel molecular drugs in minutes, rather than the months or years it would take for a classical supercomputer. The goal will be to discover and develop the next generation of oncology therapies. To see more about this partnership, you can read a news release posted on the POLARISqb website here.

January 7, 2022